Search details
1.
A Subcutaneous Implant of Tenofovir Alafenamide Fumarate Causes Local Inflammation and Tissue Necrosis in Rabbits and Macaques.
Antimicrob Agents Chemother
; 64(3)2020 02 21.
Article
in English
| MEDLINE | ID: mdl-31871073
2.
Design of a Drug-Eluting Subcutaneous Implant of the Antiretroviral Tenofovir Alafenamide Fumarate.
Pharm Res
; 37(4): 83, 2020 Apr 15.
Article
in English
| MEDLINE | ID: mdl-32296951
3.
Increases in Endogenous or Exogenous Progestins Promote Virus-Target Cell Interactions within the Non-human Primate Female Reproductive Tract.
PLoS Pathog
; 12(9): e1005885, 2016 09.
Article
in English
| MEDLINE | ID: mdl-27658293
4.
A Dose Ranging Pharmacokinetic Evaluation of IQP-0528 Released from Intravaginal Rings in Non-Human Primates.
Pharm Res
; 34(10): 2163-2171, 2017 Oct.
Article
in English
| MEDLINE | ID: mdl-28770490
5.
Repeated administration of high-dose depot medroxyprogesterone acetate does not alter SHIVSF162p3 viral kinetics and tenofovir pharmacokinetics when delivered via intravaginal rings.
J Med Primatol
; 46(4): 129-136, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28748662
6.
Preferences for Long-Acting Pre-exposure Prophylaxis (PrEP), Daily Oral PrEP, or Condoms for HIV Prevention Among U.S. Men Who Have Sex with Men.
AIDS Behav
; 21(5): 1336-1349, 2017 May.
Article
in English
| MEDLINE | ID: mdl-27770215
7.
Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges.
Proc Natl Acad Sci U S A
; 110(40): 16145-50, 2013 Oct 01.
Article
in English
| MEDLINE | ID: mdl-24043812
8.
Differential Mechanisms of Tenofovir and Tenofovir Disoproxil Fumarate Cellular Transport and Implications for Topical Preexposure Prophylaxis.
Antimicrob Agents Chemother
; 60(3): 1667-75, 2015 Dec 28.
Article
in English
| MEDLINE | ID: mdl-26711762
9.
Vaginally delivered tenofovir disoproxil fumarate provides greater protection than tenofovir against genital herpes in a murine model of efficacy and safety.
Antimicrob Agents Chemother
; 58(2): 1153-60, 2014.
Article
in English
| MEDLINE | ID: mdl-24323471
10.
Intravaginal flux controlled pump for sustained release of macromolecules.
Pharm Res
; 31(9): 2344-53, 2014 Sep.
Article
in English
| MEDLINE | ID: mdl-24789449
11.
"Set it and forget it": women's perceptions and opinions of long-acting topical vaginal gels.
AIDS Behav
; 18(5): 862-70, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24248674
12.
Novel preclinical models of topical PrEP pharmacodynamics provide rationale for combination of drugs with complementary properties.
Retrovirology
; 10: 113, 2013 Oct 24.
Article
in English
| MEDLINE | ID: mdl-24156604
13.
Safe and sustained vaginal delivery of pyrimidinedione HIV-1 inhibitors from polyurethane intravaginal rings.
Antimicrob Agents Chemother
; 56(3): 1291-9, 2012 Mar.
Article
in English
| MEDLINE | ID: mdl-22155820
14.
A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis.
Antimicrob Agents Chemother
; 56(12): 6272-83, 2012 Dec.
Article
in English
| MEDLINE | ID: mdl-23006751
15.
Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection.
J Antimicrob Chemother
; 67(7): 1730-8, 2012 Jul.
Article
in English
| MEDLINE | ID: mdl-22467632
16.
Preferences Among Physicians and Men Who Have Sex with Men (MSM) for a Long-Acting, Removable Implant for HIV Prevention: A Discrete Choice Study.
AIDS Res Hum Retroviruses
; 38(12): 898-908, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36178358
17.
Conjoint Analysis of User Acceptability of Sustained Long-Acting Pre-Exposure Prophylaxis for HIV.
AIDS Res Hum Retroviruses
; 38(4): 336-345, 2022 04.
Article
in English
| MEDLINE | ID: mdl-34779227
18.
Vaginal microbicide gel for delivery of IQP-0528, a pyrimidinedione analog with a dual mechanism of action against HIV-1.
Antimicrob Agents Chemother
; 55(4): 1650-60, 2011 Apr.
Article
in English
| MEDLINE | ID: mdl-21245437
19.
Activity and safety of synthetic lectins based on benzoboroxole-functionalized polymers for inhibition of HIV entry.
Mol Pharm
; 8(6): 2465-75, 2011 Dec 05.
Article
in English
| MEDLINE | ID: mdl-21879735
20.
Design and Testing of a Cabotegravir Implant for HIV Prevention.
J Control Release
; 330: 658-668, 2021 02 10.
Article
in English
| MEDLINE | ID: mdl-33347943